Discover why TSMC's stock has outperformed the market due to AI-driven growth, but faces challenges from geopolitical risks.
Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...
No other corporate actions details are available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback